CClinicalTrials.gg
CompletedNCT06629454Updated Oct 20, 2025Results posted

Digital Incentive Spirometry Adherence

An interventional study of Adherence to digital incentive spirometer in the postop period after major chest surgery. in Pulmonary Function, Incentive Spirometry and Patient Adherence, sponsored by University of Pennsylvania. Completed at 6 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-20.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This single-arm proof-of-concept research study aims to assess the effect of a digital incentive spirometer (IS) device and a companion mobile-based app on incentive spirometry adherence in patients post-surgery. The digital IS utilizes a sensor to measure inspiratory breaths, and these data are transmitted wirelessly to a secure cloud database. The spirometer and app include a patient reminder system, exercise gamification strategies, progress tracking, and additional features designed to promote patient IS use.

Read the detailed description

Incentive spirometry is frequently prescribed as a standard-of-care for patients post-surgery to reduce the risk of developing postoperative pulmonary complications associated with atelectasis. An incentive spirometer (IS) is a mechanical breathing device that assists with pulmonary rehabilitation through improving lung expansion by encouraging deep breathing. While performing incentive spirometry exercises is effective at lowering atelectasis severity, ventilation time, and pulmonary complication rates, patient adherence to performing exercises is very poor. Medical staff, due to time constraints, often cannot supervise all of their patients' entire incentive spirometry regimens (usually every 10-15 min during wakeful hours), contributing to low adherence and incorrect exercise completion. This is compounded by current incentive spirometers lacking a method for accurately collecting patient exercise and adherence data. The present study seeks to evaluate the effect of a digital IS that provides instruction signals and exercise reminders on patients' incentive spirometry adherence.

This single-arm proof-of-concept research study aims to assess the effect of a digital incentive spirometer (IS) device and a companion mobile-based app on incentive spirometry adherence in patients post-surgery. The digital IS utilizes a sensor to measure inspiratory breaths, and these data are transmitted wirelessly to a secure cloud database. The spirometer and app include a patient reminder system, exercise gamification strategies, progress tracking, and additional features designed to promote patient IS use.

The objective of this study is to evaluate the effect of a digital IS that provides gentle auditory and haptic reminders and exercise guidance on patient adherence to incentive spirometry. Secondarily, this study will evaluate metrics relating to lung function to assess post-surgery lung recovery in patients using the digital IS.

02

Conditions studied

  • Pulmonary Function
  • Incentive Spirometry
  • Patient Adherence
  • Lung Resection
  • Thoracic Surgery

Browse trials for

Keywords

  • Incentive spirometer
  • Patient adherence
  • Digital incentive spirometer
03

In context

Patient Compliance

114 studies on the registry are indexed under Patient Compliance; 38 are open to participants now.

This study's enrollment of 31 is below the median of 120 across 87 interventional studies indexed under Patient Compliance.

Browse Patient Compliance studies →

Lead sponsor

University of Pennsylvania is the lead sponsor of 1,635 studies on the registry; 239 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 104 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Provision of signed and dated informed consent form
  2. Stated willingness to comply with all study procedures and availability for the duration of the study
  3. Male or female, 18 years or older.
  4. Undergoes any anatomic lung resection surgery
  5. An incentive spirometer is expected to be ordered for the patient as standard-of-care
  6. There is no restriction on active medications.

Exclusion criteria

Exclusion Criteria:

There are no exclusions based on economic status, gender, race, or ethnicity. An individual who meets any of the following criteria will be excluded from participation in this study:

  1. Vulnerable populations who in the opinion of the investigator are unable to give Informed Consent for reasons of incapacity, immaturity, adverse personal circumstances or lack of autonomy.
  2. History of prior non-compliance to prescribed therapy or presence or history of significant psychiatric condition (e.g., drug or alcohol addiction, psychosis, schizophrenia), or cognitive issue which would in the opinion of the investigator, make it difficult for the patient to comply with the study procedures or follow the investigators instructions.
  3. Populations for whom in the opinion of the investigator, incentive spirometry is deemed inappropriate due to medical condition or otherwise.
  4. Pregnant individuals due to low likelihood of meeting inclusion criteria 4. Licensed medical professionals on the clinical team will follow proper procedures in determining if the individual is consenting. Proper procedures entail doing all of the following: giving a patient adequate information concerning the study, providing adequate opportunity for the patient to consider all options, responding to the patient's questions, ensuring that the patient has comprehended this information, obtaining the patient's voluntary agreement to participate and, continuing to provide information as the patient or situation requires. There will be ample opportunity for the patient to ask questions. In the event that the patient is in a vulnerable population and unable to provide consent, they will not be eligible to participate in the study and thus will not be screened. If the individual is not able to provide informed consent or if consent is not certain due to impairments or other factors, they will not be considered for study participation. In the event that the patient is in a vulnerable population and unable to provide consent, they will not be eligible to participate in the study and thus will not be screened.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    Single arm proof of concept study of a digital incentive spirometer

    This single-arm proof-of-concept research study aims to assess the effect of a digital incentive spirometer (IS) device and a companion mobile-based app on incentive spirometry adherence in patients post-surgery. The digital IS utilizes a sensor to measure inspiratory breaths, and these data are transmitted wirelessly to a secure cloud database. The spirometer and app include a patient reminder system, exercise gamification strategies, progress tracking, and additional features designed to promote patient IS use.

    Device: Adherence to digital incentive spirometer in the postop period after major chest surgery.

Interventions

  • DeviceAdherence to digital incentive spirometer in the postop period after major chest surgery.

    Major chest surgery can lead to respiratory compromise and traditional breathing exercises are not supervised or monitored. The primary objective of this study is to evaluate the effect of a multifeatured digital IS and integrated phone app on patient adherence to incentive spirometry. Together the device and app will include the following functions: an auditory and haptic reminder cue, visual and auditory cues to guide exercise completion, exercise gamification, and data tracking and visualization features.

06

What researchers measure

Primary outcomes

  1. Incentive Spirometry Adherence (Breath Attempts Per Day)

    Number of inspiratory breath attempts performed with the digital IS per day.

    Time frame: Till discharge or up to 7 days

  2. Incentive Spirometry Consistency (Hours Per Day With ≥1 Breath)

    Number of hours in which at least one inspiratory breath was attempted using the digital IS per day.

    Time frame: Till discharge or up to 7 days

Secondary outcomes

  1. Volume of Inspiratory Breaths Attempted With the Digital IS

    Inspiratory volume in milliliters measured from one inhalation from the device

    Time frame: Till discharge or up to 7 days

  2. Blood Oxygen Saturation

    Average postoperative SpO2 per patient. Mean is the mean across the patient cohort.

    Time frame: Till discharge or up to 7 days

  3. Pain Scores

    Postoperative pain scores will be reported on a scale from 0 (no pain) to 10 (unbearable pain). These are then averaged per patient. Mean and range is reported for the entirely of the patient cohort.

    Time frame: Till discharge or up to 7 days

  4. Flow Rate of Inspiratory Breaths Attempted From the Digital IS

    Flow rate over time (mL/sec) of each inspiratory breath measured from one inhalation from the device.

    Time frame: Till discharge or up to 7 days

Other outcomes

  1. Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO)

    Preoperative diffusing capacity of the lung for carbon monoxide to move from air sacs into the bloodstream as a percent of predicted value based on the person's age, sex, height, and other factors.

    Time frame: up to 2 weeks before the surgery

  2. Forced Expiratory Volume in 1 Second (FEV-1)

    Preoperative forced expiration volume in 1 second as a percentage of predicted value based on the person's age, sex, height, and other factors.

    Time frame: up to 2 weeks before the surgery

  3. Forced Vital Capacity (FVC)

    Preoperative forced vital capacity of the lungs as a percentage of predicted value based on the person's age, sex, height, and other factors.

    Time frame: up to 2 weeks before the surgery

  4. Vital Capacity (VC)

    Preoperative vital capacity of the lungs.

    Time frame: up to 2 weeks before the surgery

  5. Residual Volume (RV)

    Preoperative residual volume of the lungs as a percentage of predicted value based on the person's age, sex, height, and other factors.

    Time frame: up to 2 weeks before the surgery

  6. Total Lung Capacity (TLC)

    Preoperative total lung capacity as a percentage of predicted value based on the person's age, sex, height, and other factors.

    Time frame: up to 2 weeks before the surgery

  7. Forced Expiratory Flow (FEF25-75)

    Forced expiratory flow rate between 25% and 75% of the forced vital capacity, pre-bronchodilator, as a percentage of predicted value based on the person's age, sex, height, and other factors.

    Time frame: up to 2 weeks before the surgery

  8. Thoracic Gas Volume (TGV)

    Total gas volume within the chest cavity when the airway is temporarily blocked as a percent of predicted value based on the person's age, sex, height, and other factors.

    Time frame: up to 2 weeks before the surgery

  9. Expiratory Reserve Volume (ERV)

    Expiratory reserve volume of the lungs as a percentage of predicted value based on the person's age, sex, height, and other factors.

    Time frame: up to 2 weeks before the surgery

  10. Discharge Survey Responses - Device Engagement

    Device engagement survey responses. Patients are instructed on the paper survey to "Circle how much you agree or disagree with the following statements:"

    Time frame: On the day of patient discharge from the hospital, an average of 3 days

  11. Discharge Survey Responses - Previous Incentive Spirometry

    Have you used an incentive spirometer prior to this hospital stay?

    Time frame: On the day of patient discharge from the hospital, an average of 3 days

  12. Discharge Survey Responses - Exercise Completion Self-Reported Adherence

    Discharge Survey Question: How much of you exercises do you think you completed?

    Time frame: On the day of patient discharge from the hospital, an average of 3 days

07

Results

Posted Oct 20, 2025
Limitations and caveats
This was a single-arm, open-label study.

Participant flow

31 patients enrolled. 30 patients completed per protocol.

Participant flow — Overall Study
MilestoneSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Started31
Completed30
Not completed1
Withdrew: Withdraw by clinician decision1

Outcome measures

PrimaryIncentive Spirometry Adherence (Breath Attempts Per Day)

Number of inspiratory breath attempts performed with the digital IS per day.

Time frame:
Till discharge or up to 7 days
Reported as:
Mean · Breath attempts
Incentive Spirometry Adherence (Breath Attempts Per Day)
Breath attemptsSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Incentive Spirometry Adherence (Breath Attempts Per Day)45 (23 to 59)
PrimaryIncentive Spirometry Consistency (Hours Per Day With ≥1 Breath)

Number of hours in which at least one inspiratory breath was attempted using the digital IS per day.

Time frame:
Till discharge or up to 7 days
Reported as:
Mean · Hours
Incentive Spirometry Consistency (Hours Per Day With ≥1 Breath)
HoursSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Incentive Spirometry Consistency (Hours Per Day With ≥1 Breath)7.6 (5.75 to 10)
SecondaryVolume of Inspiratory Breaths Attempted With the Digital IS

Inspiratory volume in milliliters measured from one inhalation from the device

Time frame:
Till discharge or up to 7 days
Reported as:
Mean · milliliters
Volume of Inspiratory Breaths Attempted With the Digital IS
millilitersSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Average postoperative volume1314 (403 to 2517)
Maximum postoperative volume2375 (716 to 7506)
SecondaryBlood Oxygen Saturation

Average postoperative SpO2 per patient. Mean is the mean across the patient cohort.

Time frame:
Till discharge or up to 7 days
Reported as:
Mean · percentage of oxygen saturation
Blood Oxygen Saturation
percentage of oxygen saturationSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Blood Oxygen Saturation96 (93 to 98)
SecondaryPain Scores

Postoperative pain scores will be reported on a scale from 0 (no pain) to 10 (unbearable pain). These are then averaged per patient. Mean and range is reported for the entirely of the patient cohort.

Time frame:
Till discharge or up to 7 days
Reported as:
Mean · units on a scale from 0 to 10
Pain Scores
units on a scale from 0 to 10Single Arm Proof of Concept Study of a Digital Incentive Spirometer
Pain Scores4 (0 to 7)
SecondaryFlow Rate of Inspiratory Breaths Attempted From the Digital IS

Flow rate over time (mL/sec) of each inspiratory breath measured from one inhalation from the device.

Time frame:
Till discharge or up to 7 days
Reported as:
Mean · Milliliters per second
Flow Rate of Inspiratory Breaths Attempted From the Digital IS
Milliliters per secondSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Average flow rate186 (132 to 288)
Maximum flow rate357 (172 to 405)
Other pre-specifiedDiffusing Capacity of the Lungs for Carbon Monoxide (DLCO)

Preoperative diffusing capacity of the lung for carbon monoxide to move from air sacs into the bloodstream as a percent of predicted value based on the person's age, sex, height, and other factors.

Time frame:
up to 2 weeks before the surgery
Reported as:
Mean · percentage of predicted value
Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO)
percentage of predicted valueSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO)79.0 (26.1 to 124)
Other pre-specifiedForced Expiratory Volume in 1 Second (FEV-1)

Preoperative forced expiration volume in 1 second as a percentage of predicted value based on the person's age, sex, height, and other factors.

Time frame:
up to 2 weeks before the surgery
Reported as:
Mean · percentage of predicted value
Forced Expiratory Volume in 1 Second (FEV-1)
percentage of predicted valueSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Forced Expiratory Volume in 1 Second (FEV-1)90.6 (21.5 to 129.3)
Other pre-specifiedForced Vital Capacity (FVC)

Preoperative forced vital capacity of the lungs as a percentage of predicted value based on the person's age, sex, height, and other factors.

Time frame:
up to 2 weeks before the surgery
Reported as:
Mean · percentage of predicted value
Forced Vital Capacity (FVC)
percentage of predicted valueSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Forced Vital Capacity (FVC)94.4 (66.3 to 135.5)
Other pre-specifiedVital Capacity (VC)

Preoperative vital capacity of the lungs.

Time frame:
up to 2 weeks before the surgery

No measurements were reported for this outcome.

Other pre-specifiedResidual Volume (RV)

Preoperative residual volume of the lungs as a percentage of predicted value based on the person's age, sex, height, and other factors.

Time frame:
up to 2 weeks before the surgery
Reported as:
Mean · percentage of predicted value
Residual Volume (RV)
percentage of predicted valueSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Residual Volume (RV)108 (75.3 to 203.6)
Other pre-specifiedTotal Lung Capacity (TLC)

Preoperative total lung capacity as a percentage of predicted value based on the person's age, sex, height, and other factors.

Time frame:
up to 2 weeks before the surgery
Reported as:
Mean · percentage of predicted value
Total Lung Capacity (TLC)
percentage of predicted valueSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Total Lung Capacity (TLC)94.1 (74.3 to 123.0)
Other pre-specifiedForced Expiratory Flow (FEF25-75)

Forced expiratory flow rate between 25% and 75% of the forced vital capacity, pre-bronchodilator, as a percentage of predicted value based on the person's age, sex, height, and other factors.

Time frame:
up to 2 weeks before the surgery
Reported as:
Mean · percentage of predicted value
Forced Expiratory Flow (FEF25-75)
percentage of predicted valueSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Forced Expiratory Flow (FEF25-75)93.9 (8.2 to 189.3)
Other pre-specifiedThoracic Gas Volume (TGV)

Total gas volume within the chest cavity when the airway is temporarily blocked as a percent of predicted value based on the person's age, sex, height, and other factors.

Time frame:
up to 2 weeks before the surgery
Reported as:
Mean · percentage of predicted value
Thoracic Gas Volume (TGV)
percentage of predicted valueSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Thoracic Gas Volume (TGV)99.9 (74.7 to 155)
Other pre-specifiedExpiratory Reserve Volume (ERV)

Expiratory reserve volume of the lungs as a percentage of predicted value based on the person's age, sex, height, and other factors.

Time frame:
up to 2 weeks before the surgery
Reported as:
Mean · percentage of predicted value
Expiratory Reserve Volume (ERV)
percentage of predicted valueSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
Expiratory Reserve Volume (ERV)95.5 (29.8 to 166.9)
Other pre-specifiedDischarge Survey Responses - Device Engagement

Device engagement survey responses. Patients are instructed on the paper survey to "Circle how much you agree or disagree with the following statements:"

Time frame:
On the day of patient discharge from the hospital, an average of 3 days
Reported as:
Count of participants · Participants
Discharge Survey Responses - Device Engagement
ParticipantsSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
It was easy to know when to do my exercises with my device. — Strongly Agree14
It was easy to know when to do my exercises with my device. — Agree6
It was easy to know when to do my exercises with my device. — Neutral1
It was easy to know when to do my exercises with my device. — Disagree1
It was easy to know when to do my exercises with my device. — Strongly Disagree0
It was easy to know when to do my exercises with my device. — Incomplete2
It was easy to know when to do my exercises with my device. — Not applicable0
I felt motivated to do my exercises. — Strongly Agree7
I felt motivated to do my exercises. — Agree10
I felt motivated to do my exercises. — Neutral5
I felt motivated to do my exercises. — Disagree0
I felt motivated to do my exercises. — Strongly Disagree0
I felt motivated to do my exercises. — Incomplete2
I felt motivated to do my exercises. — Not applicable0
It was easy to click the button on my device to start an exercise when I wanted to. — Strongly Agree14
It was easy to click the button on my device to start an exercise when I wanted to. — Agree10
It was easy to click the button on my device to start an exercise when I wanted to. — Neutral0
It was easy to click the button on my device to start an exercise when I wanted to. — Disagree0
It was easy to click the button on my device to start an exercise when I wanted to. — Strongly Disagree0
It was easy to click the button on my device to start an exercise when I wanted to. — Incomplete0
It was easy to click the button on my device to start an exercise when I wanted to. — Not applicable0
I liked how the device gave spoken (audio) instructions for the exercises. — Strongly Agree9
I liked how the device gave spoken (audio) instructions for the exercises. — Agree8
I liked how the device gave spoken (audio) instructions for the exercises. — Neutral3
I liked how the device gave spoken (audio) instructions for the exercises. — Disagree2
I liked how the device gave spoken (audio) instructions for the exercises. — Strongly Disagree1
I liked how the device gave spoken (audio) instructions for the exercises. — Incomplete1
I liked how the device gave spoken (audio) instructions for the exercises. — Not applicable0
I liked how my nurse/doctor could see my breathing exercise measurements. — Strongly Agree11
I liked how my nurse/doctor could see my breathing exercise measurements. — Agree8
I liked how my nurse/doctor could see my breathing exercise measurements. — Neutral2
I liked how my nurse/doctor could see my breathing exercise measurements. — Disagree0
I liked how my nurse/doctor could see my breathing exercise measurements. — Strongly Disagree1
I liked how my nurse/doctor could see my breathing exercise measurements. — Incomplete2
I liked how my nurse/doctor could see my breathing exercise measurements. — Not applicable0
I was able to set up the app easily. — Strongly Agree6
I was able to set up the app easily. — Agree5
I was able to set up the app easily. — Neutral0
I was able to set up the app easily. — Disagree0
I was able to set up the app easily. — Strongly Disagree0
I was able to set up the app easily. — Incomplete2
I was able to set up the app easily. — Not applicable11
I liked the app features. — Strongly Agree3
I liked the app features. — Agree6
I liked the app features. — Neutral3
I liked the app features. — Disagree0
I liked the app features. — Strongly Disagree0
I liked the app features. — Incomplete2
I liked the app features. — Not applicable10
Other pre-specifiedDischarge Survey Responses - Previous Incentive Spirometry

Have you used an incentive spirometer prior to this hospital stay?

Time frame:
On the day of patient discharge from the hospital, an average of 3 days
Reported as:
Count of participants · Participants
Discharge Survey Responses - Previous Incentive Spirometry
ParticipantsSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
YES7
NO12
Incomplete5
Other pre-specifiedDischarge Survey Responses - Exercise Completion Self-Reported Adherence

Discharge Survey Question: How much of you exercises do you think you completed?

Time frame:
On the day of patient discharge from the hospital, an average of 3 days
Reported as:
Count of participants · Participants
Discharge Survey Responses - Exercise Completion Self-Reported Adherence
ParticipantsSingle Arm Proof of Concept Study of a Digital Incentive Spirometer
0-20%, Close to none0
21-40%, A few of them2
41-60%, Around half7
61-80%, More than half9
81-100%, Almost all6
Incomplete0

Adverse events

Collected over From Enrollment Until 4 Months After Discharge, up to 18 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Single Arm Proof of Concept Study of a Digital Incentive Spirometer0/30 (0%)0/30 (0%)0/30 (0%)

Baseline characteristics

The baseline analysis includes age, sex, height, weight, race, and ethnicity.

Age, Continuous
Age, Continuous(years)Single Arm Proof of Concept Study of a Digital Incentive Spirometer
Mean66 (33 to 84)
Sex: Female, Male
Sex: Female, Male(Participants)Single Arm Proof of Concept Study of a Digital Incentive Spirometer
Female17
Male13
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Single Arm Proof of Concept Study of a Digital Incentive Spirometer
Hispanic or Latino2
Not Hispanic or Latino28
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Single Arm Proof of Concept Study of a Digital Incentive Spirometer
American Indian or Alaska Native0
Asian1
Native Hawaiian or Other Pacific Islander0
Black or African American6
White22
More than one race0
Unknown or Not Reported1
Height
Height(inches)Single Arm Proof of Concept Study of a Digital Incentive Spirometer
Mean66.7 (62 to 74)
Weight
Weight(pounds (lbs))Single Arm Proof of Concept Study of a Digital Incentive Spirometer
Mean177 (75 to 269)
Procedure Target Lobe
Procedure Target Lobe(Participants)Single Arm Proof of Concept Study of a Digital Incentive Spirometer
Right Upper Lobe10
Right Lower Lobe8
Left Upper Lobe5
Left Lower Lobe3
Right Middle Lobe1
More than one lobe3
Preoperative Incentive Spirometry Volume
Preoperative Incentive Spirometry Volume(milliliters)Single Arm Proof of Concept Study of a Digital Incentive Spirometer
Average preoperative volume2066 (532 to 3941)
Maximum preoperative volume2339 (915 to 4204)

1 further baseline measures are reported on the registry.

08

Study locations

6 sites
  • Penn Medicine Cherry Hill
    Cherry Hill, New Jersey 08003, United States
  • Penn Medicine Valley Forge
    Berwyn, Pennsylvania 19312, United States
  • Hospital of the University of Pennsylvania
    Philadelphia, Pennsylvania 19104, United States
  • Penn Medicine University City
    Philadelphia, Pennsylvania 19104, United States
  • Penn Thoracic Surgery Presbyterian
    Philadelphia, Pennsylvania 19104, United States
  • Perelman Center for Advanced Medicine
    Philadelphia, Pennsylvania 19104, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Aug 19, 2024
  • Informed consent form · Nov 1, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06629454
Lead sponsor
University of Pennsylvania
Responsible party
Sponsor
First posted
Oct 8, 2024
Start date
Dec 27, 2024
Primary completion
Jul 31, 2025
Completion
Jul 31, 2025
Results posted
Oct 20, 2025
Last update
Oct 20, 2025

Study contacts

Doraid Jarrar, MD
principal investigator · University of Pennsylvania

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion